Perceptions of the COVID-19 vaccine Among Patients With Cancer: A Single-Institution Survey

Moujaess, Elissar; Zeid, Naji Bou; Samaha, Ramy; Sawan, Joud; Kourié, Hampig Raphaël; Labaki, Chris; Chebel, Roy; Chahine, Georges; Karak, Fadi El; Nasr, Fadi; Ghosn, Marwan; Wakim, Jad; Kattan, Joseph

doi:10.2217/fon-2021-0265

Cited by 40 publications

(38 citation statements)

References 16 publications

(16 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The multivariate logistic regression analyses indicated that the concern that the COVID-19 vaccine could worsen the prognosis of their cancer treatment was one of the main predictors for vaccine hesitancy ( Table 5 ). These results are similar to data from other countries: in Tunisia, 15.5% cancer patients thought the COVID-19 vaccine could impact cancer treatment outcomes or treatment efficacy [55] ; in the US, among cancer patients who refused to take the COVID-19 vaccine, 56.3% reported being concerned about the compatibility of the COVID-19 vaccine and their cancer treatment [56] .…”

Section: Discussionsupporting

confidence: 84%

Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey

Hong

Yang

et al. 2022

Journal of Integrative Medicine

View full text Add to dashboard Cite

Objective The coronavirus disease 2019 (COVID-19) pandemic has had a serious impact on health all over the world. Cancer patient, whose immunity is often compromised, faces a huge challenge. Currently, some COVID-19 vaccines are being developed and applied on general population; however, whether cancer patients should take COVID-19 vaccine remains unknown. Our study aimed to explore the knowledge, attitude, acceptance, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China. Methods A cross-sectional study was conducted in Eastern China from June 17th to September 3rd, 2021. Patients were selected using a convenience sampling method. A self-report questionnaire was developed to assess knowledge about the COVID-19 vaccine, attitude towards the vaccine and acceptance of the vaccine; following a review of similar studies previously published in the scientific literature, multivariate logistic regression analysis was used to determine the predictors associated with COVID-19 vaccine acceptance. Results A total of 2158 cancer patients were enrolled in this study. The rate of vaccine hesitancy was 24.05% (519/2158); further, among the participants of vaccine acceptance, 767 had taken COVID-19 vaccine (35.54%), and 872 were willing to get vaccinated (40.01%). A total of 24 variables including demographic characteristics, clinical status of cancer, impact of COVID-19 pandemic on study participants, patients’ knowledge about the COVID-19 vaccine, and attitude towards the vaccine, had significant differences between the “vaccine hesitancy” population and “vaccine acceptance” population. Multivariate logistic regression analysis indicated that parameters including alcohol consumption (odds ratio [OR] = 1.849; 95% confidence interval [CI]: 1.375–2.488; P -reference [ P -Ref] < 0.001 vs non-drinkers), income impacted by COVID-19 pandemic (OR = 1.930, 2.037 and 2.688 for mild, moderate, and severe impact, respectively; all P -Ref < 0.01 vs no impact), knowledge of how the vaccine was developed (OR = 1.616; 95% CI: 1.126–2.318; P -Ref = 0.009 vs unknown), believing in the safety of the vaccine (OR = 1.502; 95% CI: 1.024–2.203; P -Ref = 0.038 vs denying the safety of vaccine), willingness to pay for the vaccine (OR = 3.042; 95% CI: 2.376–3.894; P -Ref < 0.001 vs unwilling), and willingness to recommend families and friends to get vaccinated (OR = 2.744; 95% CI: 1.759–4.280; P -Ref < 0.001 vs do not recommend) were contributors to vaccine acceptance. While such as being retired (OR = 0.586; 95% CI: 0.438–0.784; P -Ref < 0.001 vs...

show abstract

Section: Discussionsupporting

confidence: 84%

Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey

Hong

Yang

et al. 2022

Journal of Integrative Medicine

View full text Add to dashboard Cite

show abstract

“…Previous studies beginning from 2020 reported a positive view of the people for the COVID-19 vaccine in most western countries varying between 59–75% [ 17 , 31–33 ]. A recent study by Mejri et al reported a vaccine acceptance rate of 50.5% from Tunisia, whereas Moujaess et al reported that 55%of the cancer patients inBeirut, Lebanon were ready to be vaccinated [ 34 , 35 ]. Nonetheless, our study that consisted of cancer patients revealed a higher COVID-19 vaccine acceptance (86.7%) than literature.…”

Section: Discussionmentioning

confidence: 99%

Impact of Corona-Phobia on Attitudes and Acceptance Towards COVID-19 Vaccine Among Cancer Patients: a Single-Center Study

Erdem

Karaman

2021

Future Oncol.

View full text Add to dashboard Cite

Aim: This study aimed to assess the impact of coronavirus disease 2019 (COVID-19) phobia and related factors on attitude towards COVID-19 vaccine in cancer patients. Methods: A prospective cross-sectional descriptive study was conducted with 300 adult patients using a validated COVID-19 Phobia Scale (C19P-S) and related survey to determine the factors affecting vaccine acceptance between May–June 2021. Results: Regarding the COVID-19 vaccine willingness, 86.7% accepted vaccination, 6.3% were hesitant and 7% refused vaccination. Patients that accepted vaccination had significantly higher C19P-S scores in general, and in psychological and psychosomatic subdivisions. Univariate analysis revealed that increased age, being retired, and being married were significantly associated with willingness to be vaccinated against COVID-19. Conclusion: The majority of patients had high coronophobia levels which were associated with increased willingness for the COVID-19 vaccines. Minimizing negative attitudes towards vaccines will most likely be achieved by raising awareness in the cancer population about COVID-19 vaccine.

show abstract

“…39 In our experience, patients who, adequately informed, refused vaccination was less than 5%, way less than data in the literature, which report refusal rates over 10%. 40,41 This might be explained by the campaign we held, that involved only professional figures of the Institute, with enrollment via proposal by treating oncologists, also testified by the high level of satisfaction shown by the patients themselves with the vaccination questionnaire.…”

Section: Discussionmentioning

confidence: 99%

Cancer Patient-Reported Experience Measures (PREMs) Regarding the Policies Implemented to Contain the Spread of Sars-CoV-2 and Vaccination Campaign at Veneto Institute of Oncology

Caccese¹,

Imbevaro²,

Feltrin³

et al. 2022

PPA

View full text Add to dashboard Cite

The SARS-CoV-2 spread has impacted Healthcare systems. COVID-19 pandemic has had consequences for patients with cancer, being associated with delays in diagnosis, in treatment And follow-up care, increase in overall infection rates and higher mortality. A survey on COVID-19 and a vaccination-questionnaire were developed at different times of the outbreak, to evaluate cancer patient-reported experience measures (PREMs) on the policies implemented to reduce the infection from SARS-CoV-2 and on the timing and methods of COVID-19 vaccination. Patients and Methods:The survey was distributed to all patients accessing the Institute during the "first-wave" Of the pandemic, evaluating patients' concerns about the pandemic, the pandemics' consequences on their cancer care, and their perception Of the measures adopted to limit the infection spread. The vaccination-questionnaire was proposed to 10% of the first 5297 cancer patients vaccinated with two doses of the Pfizer-BioNTechCOVID-19 vaccine. This questionnaire aimed at assessing the degree Of satisfaction with the Institutional vaccination campaign and vaccination-related adverse events. Results: From May 18th 2020 to June 15th 2020 the survey was completed by 3238 patients. Most of the responders expressed concern on the pandemic yet acknowledging their oncological disease as a priority. Measures implemented were appreciated by patients. Telemedicine was positively evaluated and the absence of the caregiver during the visit did not determine discomfort for two thirds of patients. From March 6th 2021 to May 8th 2021 the vaccination-questionnaire was completed by 357 patients. The 98.8% were satisfied with the vaccination campaign. No serious vaccination-correlated adverse events were reported. No patient had to delay/discontinue chemotherapy due to vaccination. Conclusion: PREMs during COVID-19 pandemic and related vaccination can provide important information to help reorganization of the health care systems for cancer care. Patients' feedback on the organizational changes implemented in the emergency period are essential for healthcare improvement and to help informed choices that are consistent with patients' needs.

show abstract

Perceptions of the COVID-19 vaccine Among Patients With Cancer: A Single-Institution Survey

Cited by 40 publications

References 16 publications

Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey

Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey

Impact of Corona-Phobia on Attitudes and Acceptance Towards COVID-19 Vaccine Among Cancer Patients: a Single-Center Study

Cancer Patient-Reported Experience Measures (PREMs) Regarding the Policies Implemented to Contain the Spread of Sars-CoV-2 and Vaccination Campaign at Veneto Institute of Oncology

Contact Info

Product

Resources

About